AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Dawson James Securities initiates coverage of HIV vaccine developer.

Vaccine Weekly

| October 01, 2003 | COPYRIGHT 2003 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Robert Wasserman, director of Research for Dawson James Securities, a division of ViewTrade Financial, has initiated coverage on Immune Response Corporation (IMNR) with a buy rating and a 12-month price target of $8-$10.

Dawson James is a research-oriented healthcare/biotech boutique investment firm with offices in Florida and New Jersey.

IMNR, based in Carlsbad, California, is developing a therapeutic vaccine for the treatment of human immunodeficiency virus (HIV) infection. Currently, IMNR is focusing its research and development efforts on Remune, an immune-based therapy for HIV infection which was been the subject of ...

Related articles from newspapers, magazines, journals, and more
Elephant Talk Announces Investment Banking Agreement with Dawson James...
Press release article from: PR Newswire May 4, 2009 700+ words
...entered into an agreement with Dawson James Securities to provide investment banking...in Boca Raton, Florida, Dawson James Securities is a full-service investment...Partner, Investment Banking, Dawson James Securities. "The universal demand...
Dawson James Securities Upgrades Antares Pharma to Strong Buy With $4.00 Price...
Press release article from: PR Newswire March 16, 2006 700+ words
...RATON, Fla., March 16 /PRNewswire/ -- Dawson James Securities, a full-service investment firm covering...Institutional Sales Desk at 561-208-2952 About Dawson James Securities: Dawson James Securities is a full-service investment firm with...
Dawson James Securities Initiates Research Coverage on CryoCor, Inc. (Nasdaq:...
Press release article from: PR Newswire August 29, 2007 700+ words
...Aug. 29 /PRNewswire/ -- Dawson James Securities, a full- service investment firm...report may be obtained by contacting Dawson James Securities at 561-391-5555. About Dawson James Securities: Dawson James Securities is a full...
Dawson James Securities Reiterates Speculative Buy Recommendation on iCAD, Inc....
Press release article from: PR Newswire May 11, 2007 700+ words
...Fla., May 11 /PRNewswire/ -- Dawson James Securities, a full- service investment firm...report may be obtained by contacting Dawson James Securities at 561-391-5555. About Dawson James Securities: Dawson James Securities is a full...
Dawson James Securities Initiates Research Coverage on Neurobiological...
Press release article from: PR Newswire January 30, 2007 700+ words
...30 /PRNewswire-FirstCall/ -- Dawson James Securities, a full-service investment firm...report may be obtained by contacting Dawson James Securities at 561-391-5555. About Dawson James Securities: Dawson James Securities is a full...
Dawson James Securities Initiates Research Coverage on TranSwitch Corp....
Press release article from: PR Newswire May 2, 2007 700+ words
...Fla., May 2 /PRNewswire/ -- Dawson James Securities, a full- service investment firm...report may be obtained by contacting Dawson James Securities at 561-391-5555. About Dawson James Securities: Dawson James Securities is a full...
Dawson James Securities Initiates Research Coverage on NovaBay Pharmaceuticals...
Press release article from: PR Newswire January 3, 2008 700+ words
...Jan. 3 /PRNewswire/ -- Dawson James Securities, a full-service investment...be obtained by contacting Dawson James Securities at 561-391-5555 or downloaded...dawsonjames.com/. About Dawson James Securities: Dawson James Securities...
Dawson James Securities Reiterates Strong Buy Recommendation on Antares Pharma...
Press release article from: PR Newswire April 2, 2007 700+ words
...Fla., April 2 /PRNewswire/ -- Dawson James Securities, a full- service investment firm...report may be obtained by contacting Dawson James Securities at 561-391-5555. About Dawson James Securities: Dawson James Securities is a full...
For more facts and information, see all results

Source: HighBeam Research, Dawson James Securities initiates coverage of HIV vaccine developer.

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA